Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II study-Reference-Cited by-同舟云学术

Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II study

Published:2003-11-19 Issue:5 Volume:123 Page:810-818
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Juliusson Gunnar,Höglund Martin,Karlsson Karin,Löfgren Christina,Möllgård Lars,Paul Christer,Tidefelt Ulf,Björkholm Magnus,

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2003.04702.x/fullpdf

Reference48 articles.

1. Sequential administration of gemtuzumab ozogamicin and intensive chemotherapy for remission induction in previously untreated patients with AML over the age of 60: interim results of the EORTC Leukemia Group AML-15A phase II trial;Amadori;Blood,2001

2. Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study;Anderson;Blood,2002

3. Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720;Baer;Blood,2002

4. A randomized study of high-dose cytarabine in induction in acute myeloid leukemia;Bishop;Blood,1996

5. Intensified induction chemotherapy with high dose cytarabine and etoposide for acute myeloid leukemia: a review and updated results of the Australian Leukemia Study Group;Bishop;Leukemia & Lymphoma,1998

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spectrum of infections in different regimens of post-induction chemotherapy in acute myeloid leukemia (de-novo): A comparative retrospective study;Heliyon;2024-02

2. Early changes in gene expression profiles in AML patients during induction chemotherapy;BMC Genomics;2022-11-14

3. Homoharringtonine combined with cladribine and aclarubicin (HCA) in acute myeloid leukemia: A new regimen of conventional drugs and its mechanism;Oxidative Medicine and Cellular Longevity;2022-07-13

4. Efficacy and safety of cladribine addition to induction treatment of newly diagnosed acute myeloid leukemia: a systematic review and meta-analysis;Hematology;2021-01-01

5. CLAG-M chemotherapy followed by umbilical cord blood stem cell transplantation for primary refractory acute myeloid leukaemia in a child: A case report;World Journal of Clinical Cases;2020-11-26